Ernexa Therapeutics Inc. (ERNA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -2.26M | -1.15M | -1.27M | -2.53M | -2.06M | -3.54M | -6.29M | -2.26M | -3.75M | -4.66M | -5.83M | -3.87M | -6.05M | -5.43M | -6.12M | -3.99M | -5.43M | -6.83M | -6.42M | -6.8M |
| Operating CF Margin % | - | - | - | - | - | -354500% | -1290.55% | -4806.38% | -7972.34% | -27417.65% | -11423.53% | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -9.64% | 67.62% | 79.76% | -12.08% | 44.89% | 23.94% | -7.88% | 41.66% | 38.06% | 14.24% | 4.74% | 3.03% | -11.36% | 20.45% | 4.78% | 41.32% | -58.37% | -317.17% | - | - |
| Net Income | -5.51M | -1.5M | -1.24M | -3.14M | -8.2M | -5.76M | -26.6M | -5.53M | -6.65M | -6.15M | -5.59M | -4.51M | -5.42M | -4.49M | -7.32M | -3.4M | -9.38M | -7.95M | -86.06M | -10.09M |
| Depreciation & Amortization | 86K | 69K | 70K | 55K | 69K | 68K | 451K | 578K | 541K | 481K | 517K | 63K | 62K | 86K | 121K | 152K | 138K | 123K | 123.42K | 117.28K |
| Stock-Based Compensation | 0 | 333K | 293K | 368K | 502K | 410K | 405K | 423K | 282K | 165K | 0 | 214K | 689K | 397K | 476K | 879K | 1.18M | 0 | 1.73M | 1.4M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -297.28K | 50K |
| Other Non-Cash Items | 2.45M | 2K | -374K | 690K | 5.34M | 3.16M | 22.74M | 517K | 1.1M | 491K | 206K | 393K | 96K | -1.09M | -845K | -3.83M | 2.22M | 1.93M | 80.61M | -249.91K |
| Working Capital Changes | 707K | -50K | -21K | -506K | 226K | -1.43M | -3.28M | 1.75M | 980K | 355K | -958K | -34K | -1.48M | -343K | 1.45M | 2.21M | 399K | -936K | -2.53M | 1.96M |
| Change in Receivables | 750K | -692K | 0 | 2K | 281K | -250K | 41K | 123K | 74K | 1.35M | -792K | -337K | 304K | -25K | -232K | 141K | -146K | -664K | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 759K | 223K | 0 | -410K | -53K | -575K | -791K | 1.09M | 461K | -4.11M | 1.67M | 1.31M | -1.77M | 0 | -919K | 1.81M | 486K | -289K | -2.84M | 3.61M |
| Cash from Investing | -2K | -15K | -22K | 0 | 0 | 0 | -19K | -249K | -97K | -19K | 0 | 0 | 0 | 129K | -43K | -87K | -46K | -147K | -22.86M | -466 |
| Capital Expenditures | -2K | -15K | -22K | 0 | 0 | 0 | -19K | -249K | -101K | -19K | 0 | 0 | 0 | -21K | -43K | -187K | -46K | -147K | -6.86K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | 3.9% | 529.79% | 214.89% | 111.76% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.85M | -466 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 150K | 0 | 100K | 0 | 0 | 0 | 0 |
| Cash from Financing | 9.56M | 0 | 26K | 4.93M | 2.25M | 1.01M | 3.89M | -22K | 1.39M | 7.7M | 8.54M | 312K | 0 | 7.59M | 6K | -13K | 11.99M | -419K | 3.5M | 48.56M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 2.25M | 0 | 3.89M | 0 | 1.41M | 7.71M | 8.54M | 0 | 0 | -1K | -1K | 0 | 0 | -410K | 0 | 0 |
| Equity Issued (Net) | 9.56M | 0 | 0 | 4.93M | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 320K | 0 | 7.71M | 0 | 0 | 11.99M | 10.5M | 3.5M | 38.06M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 8K | 0 | 0 | 0 | -8K | 0 | 0 | 0 | -8K | 0 | 0 | 0 | -8K | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 26K | 0 | 0 | 1M | 0 | -22K | -20K | 0 | 0 | -8K | 0 | -111K | 7K | -13K | 0 | -10.5M | 0 | 10.5M |
| Net Change in Cash | 7.29M | -1.16M | -1.27M | 2.4M | 189K | -2.54M | 1.68M | -2.53M | -2.46M | 3.02M | 2.71M | -3.56M | -6.05M | 2.29M | -6.15M | -4.09M | 6.51M | -7.4M | -25.78M | 41.75M |
| Free Cash Flow | -2.27M | -1.16M | -1.29M | -2.53M | -2.06M | -3.54M | -6.3M | -2.51M | -3.85M | -4.68M | -5.83M | -3.87M | -6.05M | -5.46M | -6.16M | -4.18M | -5.48M | -6.98M | -6.43M | -6.8M |
| FCF Margin % | - | - | - | - | - | -354500% | -1294.46% | -5336.17% | -8187.23% | -27529.41% | -11423.53% | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -9.73% | 67.19% | 79.47% | -0.96% | 46.34% | 24.25% | -8.2% | 35.23% | 36.39% | 14.22% | 5.41% | 7.37% | -10.42% | 21.82% | 4.21% | 38.57% | -59.71% | -322.83% | - | - |
| FCF per Share | -2.86 | -3.70 | -3.93 | -12.22 | -0.97 | -1.72 | -29.13 | -11.59 | -17.78 | -21.63 | -26.92 | -18.25 | -29.50 | -30.99 | -52.35 | -35.54 | -51.08 | -67.06 | -63.61 | -80.15 |
| FCF Conversion (FCF/Net Income) | 0.41x | 0.76x | 1.03x | 0.81x | 0.25x | 0.62x | 0.24x | 0.41x | 0.56x | 0.76x | 1.04x | 0.86x | 1.12x | 1.21x | 0.84x | 1.18x | 0.58x | 0.86x | 0.07x | 0.67x |
| Interest Paid | 0 | 0 | 1K | 0 | 0 | 2K | 0 | 6K | 0 | 0 | 0 | 12K | 1K | 5K | 11K | 13K | 1K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 4K | 0 | 7K | 0 | 8K | 0 | 0 | 0 | 0 |